Professional Journey
Director and Clinical Administrator, Radiation Oncology at Max Institute of Cancer Care, Max Super Speciality Hospital, Saket, Delhi. Fellow, Proton Beam Therapy and Precision Radiation Oncology Cancer Institute of New Jersey, USA
Dr. Dodul Mondal is one of the most prominent and dynamic clinical oncologist and radiation oncologists of India with international repute who has an experience of working with Proton Beam Therapy at one of the largest university hospitals in the United States. Proton Beam Therapy is considered as the most precise form of radiation currently available in the world. At present, he has been working as Director and Clinical Administrator, Radiation Oncology Max Institute of Cancer Care, Max Super Speciality Hospital, Saket, Delhi.
Dr. Mondal has a vast experience of working at almost all leading high volume cancer institutes of India including Tata Memorial Hospital (TMH), Mumbai; All India Institute of Medical Sciences (AIIMS), New Delhi and Sanjay Gandhi Post Graduate Institute of Medical Sciences (SGPGI), Lucknow.He went to USA as a fellow in Precision Radiation Oncology and Proton Beam Therapy at Cancer Institute of New Jersey, Robert Wood Johnson University Hospital, Rutgers University.
He also worked at Abramson Cancer Center at Pennsylvania University in United States as a visiting scholar. Best Oncologist in Delhi NCR.
Show More
Dr Mondal is mainly involved in cancer diagnosis, treatment, screening and early detection of cancers, genetic screening of cancer and cancer prevention. He treats patients with high energy precision radiation. He is highly experienced with Stereotactic Radio Surgery (SRS), Stereotactic Radiation Therapy (SRT), Stereotactic Body Radiotherapy (SBRT), Image Guided Radiotherapy (IGRT), Intensity Modulated Radio Therapy (IMRT), Rapid Arc, VMAT, Tomotherapy etc. He is also highly skilled in brachytherapy including interstitial brachytherapy for different cancers.
A medical student of Nilratan Sircar Medical College and Hospital, Kolkata, Dr Mondal was well known for his academic excellence and used to be one of the toppers in his institute. He bagged multiple awards and honors and also was awarded with gold medal as a mark of his success. He did his specialty training in Radiation Oncology from Medical College Hospital, Kolkata (erstwhile Calcutta Medical College) which is the oldest medical college of Asia, having a rich history of radiation oncology for more than a century. Dr Mondal was one of the university toppers during final exit exam as well.Best Oncologist in Delhi, He was conferred with honorary membership of National Academy of Medical Sciences awarded by National Board of Examinations of India.
Dr Mondal has published multiple articles in different national and international journals. He has also contributed to national and international textbooks as an author. He is a reviewer of multiple peer reviewed indexed oncology journals.
Show Less
Languages known:
English, Bengali, Hindi.
Area Of Interest And Expertise
- Proton Beam Therapy (considered as the most precise form of radiation)
- High precision radiation including Stereotactic Radio Surgery (SRS), Stereotactic Radiation Therapy (SRT), Stereotactic Body Radiotherapy (SBRT), Image Guided Radiotherapy (IGRT), Intensity Modulated Radio Therapy (IMRT), Rapid Arc, VMAT, Tomotherapy etc.
- Brachytherapy including intracavitary brachytherapy, interstitial brachytherapy, surface moulds. This technique is usually not practiced by many as it requires high motivation and skill to perform the procedures. Many times, these involve anesthesia and specialized care.
- Hypofractionated radiotherapy including APBI
Textbooks
- Mondal D, et al. “Brachytherapy.” In: Precision Radiation Oncology. Ed. Bruce G. Haffty, Sharad Goyal. United States: Rutgers University Press, 2018. 115-48. Print.
- Mondal D. “Radiation and chemotherapy in management of malignant sinonasal tumors.” In: Sinonasal Imaging (Clinico radiological series). Ed. A. Bhalla, M. Jana. India: Jaypee Medical Publishers, 2018. 209-15. Print.
- Mondal D. “Radiation in lung cancer” in: Imaging of Chest Tumors (Clinico Radiological Series). Ed. Bhalla A, Jana M. India: Jaypee Medical Publishers, 2019. Print.
Professional Membership
- Fellow, UICC (USA)
- American Society for Radiation Oncology
- European Society of Radiotherapy and Oncology
- Indian College of Radiation Oncology
- Association of Radiation Oncologists of India
- Indian Society of Oncology
Publications
- Mondal D, Julka PK, Sharma DN, Laviraj MA, Jana M, Kamal VK, et al. Dual partial arc volumetric modulated arc therapy: The game changer for accelerated hypofractionated whole breast radiotherapy with simultaneous integrated tumor cavity boost in early breast cancer A comparative dosimetric study with single partial arc volumetric modulated arc therapy. J Can Res Ther 2019 Jul-Sep;15(5):1005-1010.
- Mondal D, Julka PK, Sharma DN, Jana M, Laviraj MA, Deo SV et al. Accelerated hypofractionated adjuvant whole breast radiation with simultaneous integrated boost using volumetric modulated arc therapy for early breast cancer: A phase I/II dosimetric and clinical feasibility study from a tertiary cancer care centre of India. J Egypt Natl Canc Inst. 2017 Mar;29(1):39-45.
- Sahai P, Singh G, Mondal D, Suri V, Julka PK. Solitary fibrous tumor of the sellar region treated with adjuvant radiation therapy. Asian J Neurosurg. 2016 Oct-Dec;11(4):449. DOI: 10.4103/1793-5482.145186.
- Mondal D, Sharma DN. External beam radiation techniques for breast cancer in the new millennium: New challenging perspectives, J Egyptian Nat Cancer Inst (2016), http://dx.doi.org/10.1016/j.jnci.2016.08.001.
Show More
- Adhikari N, Mondal D, Jana M, Kumari K, Das KJ, Julka PK. Primary Neuroendocrine Tumor of Seminal Vesicle: An Extremely Rare Clinical Entity Emphasizing Diagnostic Role of 68-Ga DOTANOC PET-CT Scan and Therapeutic Potential of Long-Acting Depot Octreotide Injection in Maintenance. Clin Genitourin Cancer. 2016 Oct;14(5):e539-e543. doi: 10.1016/j.clgc.2016.04.020.
- Roy S, Mondal D, Melgandi W, Jana M, Chowdhury KK, Das S, et al. Impact of post-operative radiation on coronary arteries in patients of early breast cancer: A pilot dosimetric study from a tertiary cancer care center from India. Indian J Cancer. 2015 Jan-Mar;52(1):114-7. doi: 10.4103/0019-509X.175562.
- Mondal D, Jana M, Sur PK, Khan EM.Primary Sinonasal meningioma in a child. Ear, Nose & Throat Journal. 2015 Sep; 94(9):E7-9.
- Mondal D, Julka PK, Jana M, Walia R, Chaudhuri T. Langerhans cell histiocytosis of atlantoaxial joint in a middle-aged man presenting with deafness as first symptom and soft-tissue mass at neck showing excellent response to radiotherapy alone: Report of an extremely rare and unusual clinical condition and review of literature. Ann Indian Acad Neurol. 2014 Oct;17(4):429-32. doi: 10.4103/0972-2327.144022.
- Mondal D, Rastogi N, Chaudhuri T, Jana M. Synchronous papillary urothelial carcinoma of urinary bladder and adenocarcinoma of stomach in a middle-aged man: An extremely rare association with therapeutic dilemma. Clin Cancer Investig J. 2013; Jul, 2 (2):156-159.
- Jana M, Chandraskekhara SH, Chaudhuri T, Julka PK, Mondal D. Peritoneal lymphomatosis mimicking peritoneal carcinomatosis – a clinical dilemma: Series of two cases and review of literature. Clin Cancer Investig J.2013 Oct-Dec 2(4): 356-358.
- Chaudhuri T, Mondal D, Yadava K, Kamlesh Yadava. Symptomatic trigeminal neuralgia as the first presentation of acute lymphoblastic leukemia. Ann Indian Acad Neurol. 2013 Jul;16(3):463-4. doi: 10.4103/0972-2327.116962.
- Mondal D, Jana M, Julka PK, Arava SK. An uncommon cause of headache: Oman Med J. 2013 Sep;28(5):371-2. doi: 10.5001/omj.2013.105.
- Chaudhuri T, Mondal D. Comment on: ‘‘Increased treatment-related mortality with additional Cisplatin-based chemotherapy in patients with nasopharyngeal carcinoma treated with standard radiotherapy’’. Radiother Oncol. 2013 Mar;106(3):411. doi: 10.1016/j.radonc.2013.03.008
- Mondal D, Jana M, Julka PK. Supratentorial atypical teratoid rhabdoid tumor: An uncommon childhood tumor: J Pediatr Neurosci. 2011 Jan;6(1):90-1. doi: 10.4103/1817-1745.84423.
- De S, Ghosh S, Mondal D, Sur PK. Osteosarcoma of the Mandible - second cancer in a case of Hodgkin’s Lymphoma post- chemotherapy. J Cancer Res Ther. 2010 Jul-Sep;6(3):336-8. doi: 10.4103/0973-1482.73349.
- Mondal D, Kundu S, Chattopadhyay S, De S, Dastidar AG, Roy A.. Carcinoma in situ of true vocal cord in a non-smoker adolescent female. Indian J Med Paediatr Oncol. 2009 Jan;30(1):43-5. doi: 10.4103/0971-5851.56337.
- S.Kundu, S.Chatterjee, D.Mondal, A.G.Dastidar, A.Roy. Myoepithelial Carcinoma in Infratemporal Fossa. Indian Journal of Medical and Paediatric Oncology: 2008: 29: 3: 23-25. S.Kundu, S.Chatterjee, D.Mondal, A G Dastidar, A.Roy. Extramedullary Granulocytic sarcoma. Indian Journal of Medical and Pediatric Oncology: 29:3:28-30.
- S.Kundu, S.Chatterjee, Mondal D, DAstidar AG, Roy A. Extramedullary Granulocytic Sarcoma. Indian Journal of Medical and Pediatric Oncology. Vol. 29 No 3, 2008.
Show Less
Conference Presentations
- Proton versus Photon breath hold radiation for left sided breast cancer after breast-conserving surgery: A dosimetric comparison (Annual conference of American Society for Radiation Oncology 2019, Chicago, USA)
- Acute toxicity in female patients having early breast cancer treated with hypofractionated whole breast radiotherapy with simultaneous integrated boost using Volumetric Modulated Arc Therapy: A feasible complex novel approach. (World Cancer Congress, Paris, France, 2016)
Show More
- Adjuvant hypofractionated whole breast radiotherapy with Simultaneous Integrated Boost using Volumetric Modulated Arc Therapy in early breast cancer patients: Dosimetric feasibility of a promising time saving novel radiation technology. (World Cancer Congress, Paris, France, 2016)
- PFT change during adjuvant hypofractionated radiation with simultaneous integrated boost for EBC (14th St Gallen Breast Cancer Conference, Vienna, 2015)
- Axillary nodal burden and chemotherapy influences PCR in advanced breast cancer treated with NACT (14th St Gallen Breast cancer Conference, Vienna, March 2015)
- High mitotic index is associated with poor survival in patients with intracranial meningioma (AROICON, Imphal, Manipur, India, 2014)
- Impact of post-operative radiation on left anterior descending artery in patients of early breast cancer: A pilot dosimetric study from a tertiary cancer care centre from India (9th European Breast Cancer Congress, Glasgow, Scotland, March-2014)
- IMRT in carcinoma anal canal: Initial dosimetric analysis of a prospective study (ECCO-2013, Amsterdam, Netherlands, 2013)
- A comparative study between preoperative and postoperative chemoradiation in locally advanced rectal carcinoma (AROICON, Mumbai, India, November 2008)
Show Less
Extracurricular Activities
- An ardent lover of literature, Dr Mondal loves reading literary works of renowned authors.
- When not in clinics, Dr Mondal loves watching birds and is avidly interested in bird photography.
- Driving is another passion and he enjoys going out for long drives. He also got a professional training in Tagore songs and Indian classical music.
Frequently Asked Questions
What is Cancer ?
Cancer is the uncontrolled growth of body cells that invade the surrounding normal tissues. If not checked in time, it will spread to distant organs.
What cause Cancer ?
There is no single cause of cancer. Doctors believe that cancer is caused by a combination of many factors. The factors involved may be the individual’s genetic, environmental or physical characteristics.
Can injuries cause Cancer ?
Can injury cause cancer? It is a common myth that injuries can cause cancer. But the truth is that falls, bruises, fractures or other similar injuries have nothing to do with cancer. Sometimes a person may see a health care provider for what was believed to be the cause of injury and cancer at the time.
Can stress cause Cancer ?
No, being stressed does not increase the risk of cancer. Over the past few years, studies have studied many people, but there is no evidence that people with greater stress are more likely to develop cancer. However, how you cope or deal with stress may affect your health.
Is Cancer contagious ?
In the past, people often stayed away from people with cancer. They are worried that they will “infect” the disease. But cancer is not like flu or cold. You cannot get cancer from someone who has cancer. You will not get cancer from people around you or people who have cancer. Don’t be afraid to visit someone with cancer. They need the support of family and friends.
Can Cancer be cured ?
Cure means that the treatment has eradicated cancer and there is no chance that it will return. It is rare that a doctor can ensure that cancer will never return. In most cases it takes time and the longer a person remains cancer-free, the better chance cancer will not return.
Who gets cancer ?
Anyone can get cancer, although the risk increases with age. Your personal risk depends on many factors, such as whether you smoke, lifestyle choices (such as diet and exercise), family history of cancer, and factors in the workplace and environment.
How many people alive today have ever had cancer ?
Today, almost 17 million people alive in the United States have had some type of cancer. Some of these people are cancer-free; others still have it.
How is cancer Treated ?
Surgery, chemotherapy and radiation are the three main cancer treatments. Cancer patients may receive any or all of these treatments. When choosing a treatment plan, the most important factors are usually the type of cancer and the stage (amount) of the cancer.
Is cancer treatment worse than cancer ?
When many people decide whether to receive cancer treatment, this belief can be dangerous for many people. People who believe that treatment is worse than cancer may not have access to life-saving treatments.
Is cancer genetic ?
In fact, cancer is a genetic disease. This is because cancers are caused by mutations or changes in genes that control the way our cells function, causing them to behave abnormally. These mutations can be inherited and account for about 5% to 10% of all cancer cases, but the changes in these genes are likely to occur during a person’s lifetime due to factors other than human genetics.